BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q3 EPS by 16c

October 25, 2012 4:08 PM

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q3 EPS of ($0.04) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found